Delivery Order SPE2DB22D3004-SPE2DB25FNE98

Award Date 10/15/24
Potential Completion Date 11/5/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $3,951.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of May 6, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,996.51 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and a period of performance through December 18, 2024. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract, valued at $2,996.51, is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. This is a firm fixed-price delivery order contract with a completion date of January 13, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the pharmaceutical product SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,896.41, and has a period of performance through November 13, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product, with a ceiling value of $3,951.86 and a period of performance through April 14, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML pharmaceutical products. The firm fixed price contract has a potential value of $2,896.41 and a completion date of March 27, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not designated as a set-aside contract. In addition to this delivery order,...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product, with a ceiling value of $11,855.58 and a period of performance ending on May 9, 2025. The contract is not set aside and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,903.74, is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a performance period through March 19, 2025. This award is not designated as a set-aside contract. AmerisourceBergen also holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $2,896.41 and a completion date of September 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the DLA to efficiently procure a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product, and has a ceiling value of $23,711.16. The contract is a firm fixed-price delivery order with an ultimate completion date of January 29, 2025. This award is not designated as a set-aside...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNE98
    Delivery Order

This federal contract award is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML pharmaceutical product, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,896.41 and a period of performance through November 5, 2024. This contract is not a set-aside award. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare programs nationwide.

Generated 1/14/25, 9:11 AM